A Model of Reoxygenation Dynamics of Head-And-Neck Tumors Based on Serial 18F-Fluoromisonidazole Positron Emission Tomography Investigations

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 2, 2007, Pages 515-521

  Thorwarth, Daniela ^a   Eschmann, Susanne Martina ^a   Paulsen, Frank ^a   Alber, Markus ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

FMISO PET; Hypoxia; Radiotherapy; Reoxygenation; Tumor control probability

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DRUG PRODUCTS; OXYGENATION; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY; TUMORS;

FMISO PET; HYPOXIA; REOXYGENATION; TUMOR CONTROL PROBABILITY;

ONCOLOGY;

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18;

ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARTMENT MODEL; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; HYPOXIA; MOLECULAR DYNAMICS; MOLECULAR MODEL; PERFUSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REOXYGENATION;

ALGORITHMS; CELL HYPOXIA; HEAD AND NECK NEOPLASMS; HUMANS; MISONIDAZOLE; MODELS, BIOLOGICAL; OXYGEN; POSITRON-EMISSION TOMOGRAPHY; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE; TUMOR BURDEN;

EID: 34247871556     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.12.037     Document Type: Article

References (22)

1. Eschmann S.M., Paulsen F., Reimold M., et al. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. J Nucl Med 46 (2005) 253-260
2. Hicks R.J., Rischin D., Fisher R., et al. Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent. Eur J Nucl Med Mol Imaging 32 (2005) 1384-1391
3. Rasey J.S., Koh W.J., Evans M.L., et al. Quantifying regional hypoxia in human tumors with positron emission tomography of [F-18]fluoromisonidazole. Int J Radiat Oncol Biol Phys 36 (1996) 417-428
4. 18F-fluoroazomycin arabinoside. J Nucl Med 46 (2005) 106-113
5. 60Cu-ATSM: Relationship to therapeutic response-a preliminary report. Int J Radiat Oncol Biol Phys 55 (2003) 1233-1238
6. Nordsmark M., and Overgaard J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother Oncol 57 (2000) 39-43
7. Nordsmark M., Overgaard M., and Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 41 (1996) 31-39
8. Kaanders J.H.A.M., Bussink J., and van der Kogel A. ARCON: A novel biology-based approach in radiotherapy. Lancet Oncol 3 (2002) 728-737
9. Rischin D., Hicks R.J., Fisher R., et al. Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: A substudy of Trans-Tasman Radiation Oncology Group Study 98.02. J Clin Oncol 24 (2006) 2098-2104
10. Overgaard J., Eriksen J.G., Nordsmark M., et al. Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: Results from the DAHANCA 5 randomised double-blind placebo-controlled trial. Lancet Oncol 6 (2005) 757-764
11. Alber M., Paulsen F., Eschmann S.M., et al. On biologically conformal boost dose optimization. Phys Med Biol 48 (2003) N31-N35
12. Chao K.S., Bosch W.R., Mutic S., et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 49 (2001) 1171-1182
13. Bentzen S.M. Theragnostic imaging for radiation oncology: Dose-painting by numbers. Lancet Oncol 6 (2005) 112-117
14. Ling C.C., Humm J., Larson S., et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 47 (2000) 551-560
15. Gray L.H., Conger A.D., Ebert M., et al. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 26 (1953) 638-648
16. Ljungkvist A.S.E., Bussink J., Rijken P.F.J.W., et al. Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 54 (2002) 215-228
17. Ljungkvist A.S.E., Bussink J., Kaanders J.H.A.M., et al. Hypoxic cell turnover in different solid tumor lines. Int J Radiat Oncol Biol Phys 62 (2005) 1157-1168
18. Thorwarth D., Eschmann S.M., Scheiderbauer J., et al. Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer. BMC Cancer 5 (2005) 152
19. 18F]-Fmiso PET data to analyse tumor hypoxia. Phys Med Biol 50 (2005) 2209-2224
20. Coleman C.N., Mitchell J.B., and Camphausen K. Tumor hypoxia: Chicken, egg, or a piece of the farm?. J Clin Oncol 20 (2002) 610-615
21. Ljungkvist A.S.E., Bussink J., Kaanders J.H.A.M., et al. Dynamics of hypoxia, proliferation and apoptosis after irradiation in a murine tumor model. Radiat Res 165 (2006) 326-336
22. Popple R.A., Ove R., and Shen S. Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation. Int J Radiat Oncol Biol Phys 54 (2002) 921-927